Graves' Disease
Medical Gaslighting Is Real: The Appointment That Changed Everything
Editor’s Note: We’re honored to share part 4 of 10 of an ongoing blog series, originally written by Elena Genik. When You Go to a
Moderna and Recordati Partner on mRNA‑3927 for Propionic Acidemia: Clinical Development Advances Toward Pivotal Readout
- February 9, 2026
Nanoparticles Targeting Tumors Eliminates Most Chemotherapy Side Effects
Turning Heart Data Into an Early Warning System for Vision Loss
New Immunotherapy Strategy Targets Tumor ‘Bodyguards,’ Shows Powerful Results in Preclinical Cancer Models
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
MPS I (Hurler Syndrome)
FDA Places Clinical Holds on REGENXBIO’s MPS Gene Therapy Programs After Tumor Detected in Trial Participant
As reported on drugs.com, REGENXBIO has disclosed that the U.S. Food and Drug Administration has halted clinical testing of its investigational gene therapies RGX‑111 and
Myelofibrosis
James’ Story: Navigating Life with Myelofibrosis
Editor’s Note: Patient Worthy is honored to share this patient story, provided to us by our friends at Heal Canada, and originally written for the
Obesity
Roche’s Obesity Drug Shows Promise Against Lilly and Novo Nordisk
Roche has announced encouraging results from its Phase II trial of CT-388, an experimental obesity treatment that achieved placebo-adjusted weight loss of 22.5% over 48
Squamous-cell carcinoma
EMA Endorses First Immunotherapy Option for Advanced Anal Cancer
The European Medicines Agency (EMA) has issued a positive opinion recommending that retifanlimab (Zynyz) be approved for an expanded indication to treat adults with advanced
Graves' Disease
The Invisible Battle No One Warned Me About: Developing Thyroid Eye Disease
Editor’s Note: Patient Worthy is honored to share part 3 in an ongoing 10-part series, written and shared with us by Elena Genik. When My
Thyroid eye disease
Artificial Intelligence Advances Eye Disease Diagnosis: Deep Learning Shows Promise in Distinguishing Thyroid Eye Disease from Orbital Myositis
Researchers have developed an innovative deep learning model capable of accurately differentiating thyroid eye disease (TED) from orbital myositis using computed tomography (CT) imaging, potentially
Hunter Syndrome
FDA Places Clinical Hold on REGENXBIO’s MPS Gene Therapy Programs After Tumor Case Review
As reported on Drugs.com, REGENXBIO has announced that the U.S. Food and Drug Administration (FDA) has halted clinical testing of its investigational gene therapies RGX‑111
Pancreatic Cancer
An International Team of Researchers Identify a New Key Factor Influencing Pancreatic Cancer
Several highly esteemed Institutes such as the Mayo Clinic and CONICET have identified critical elements contributing to the aggressiveness of Pancreatic cancer. The survival rate
Melanoma
Personalized Cancer Vaccine Shows Long-Term Protection Against Melanoma Recurrence
Moderna and Merck have announced promising five-year data for a groundbreaking personalized cancer treatment that combines mRNA technology with immunotherapy to prevent melanoma from returning
Breast Cancer
Two-Decade-Old Cancer Vaccine Study Reveals Clues to Long-Term Survival
As reported on Science Daily, a breast cancer vaccine tested more than 20 years ago is drawing renewed scientific interest after researchers discovered that every
Graves' Disease
When Healing Goes Wrong: How I Accidentally Triggered My Graves Disease
Editor’s Note: Patient Worthy is honored to share part 2 in an ongoing 10-part series, written and shared with us by Elena Genik. Before the
Cancer
Why Most Cancer Patients Don’t Benefit from Modern Immunotherapy, And Why Your Heart Medication Might Change That
Cancer immunotherapy represents one of modern medicine’s greatest achievements, yet it’s also one of its most frustrating paradoxes: a treatment that works miracles for some
Propionic Acidemia
Moderna Partners With Recordati to Advance mRNA Therapy for Propionic Acidemia
As reported on BioSpace, Moderna has entered a commercialization partnership with Italy‑based Recordati to support the development of mRNA‑3927, an investigational mRNA therapy for propionic
Osteosarcoma
How Artificial Intelligence Can Transform the Fight Against Childhood Osteosarcoma
Osteosarcoma is a diagnosis no family should ever have to face. It is the most common primary bone cancer in children and adolescents, yet treatment
Dementia
The Weight of Prevention: How Obesity and Hypertension Directly Trigger Dementia
A groundbreaking genetic study published in The Journal of Clinical Endocrinology & Metabolism and reported by ScienceDaily.com has revealed that obesity and high blood pressure
Prostate Cancer
A 20-Year Journey Through Prostate Cancer, Recurrence, and Modern ADT: A Patient’s Perspective on What Clinicians Need to Know
Twenty years is a long time to believe a cancer chapter has closed. For two decades after my radical prostatectomy, I lived with the quiet
Graves' Disease
The Day My Life Changed: My Unexpected Graves Disease Diagnosis
Editor’s Note: Patient Worthy is honored to share part 1 in an ongoing 10-part series, written and shared with us by Elena Genik. When Everything
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
This week on Patient Worthy, we’re shining a spotlight on Retinal Vein Occlusion (RVO).
RVO can feel overwhelming, isolating, or unexpected, but your experience matters! That’s why throughout the week, we’ll be sharing meaningful insights, uplifting patient voices, and creating a space where individuals and caregivers can speak openly about their journeys.
Whether you’ve faced sudden vision changes, navigated treatment, or are still searching for answers, your story has the power to guide and encourage someone else walking a similar path.
💜 Want to learn more or join the conversation?
Visit patientworthy.com for the latest updates, resources, and real patient perspectives.
📣 Have a story to share?
Click the link below, we’d be honored to hear your journey.
bit.ly/4dV7gru
Your voice could be the light someone else needs today.
#RVO #RetinalVeinOcclusion #EyeHealth #PatientWorthy #ShareYourStory
💜 Today is International Epilepsy Day 💜
This day is for everyone who wakes up and keeps going even when life feels uncertain. Epilepsy brings challenges that are hard to explain yet somehow you continue to show up for yourself and for the people you love. That kind of strength is real and it deserves to be seen.
If you live with epilepsy you are not defined by it. You are shaped by the courage it takes to move through each day and still hold on to hope. You are proof that a complicated journey can still be a beautiful one.
If you have a story to share we would be honored to hear it. Your voice can bring comfort to someone who needs to know they are not walking this road alone.
💜 You matter
💜 Your experience matters
💜 Your light matters
#InternationalEpilepsyDay #epilepsyawareness #youarenotalone #PatientWorthy
Nanoparticles Targeting Tumors Eliminates Most Chemotherapy Side Effects bit.ly/45QDUId Read now at PatientWorthy.com
#PatientWorthy #chemotherapy #sideeffects
